- Home
- Paediatrics
- Clinical Safety Evaluation of a Pentavalent DTaP-IPV/Hib Combination Vaccine
1w3 min read
Medical Article
Introduction Pentacel, a combination vaccine developed against Diphtheria, Tetanus, acellular Pertussis Inactivated Poliovirus, Haemophilus influenzae type b (DTaP-IPV-Hib) to provide immunogenic protection (1). Regulatory standards mandate that combination platforms demonstrate immunologic equivalence or clinically relevant antibody responses when

Clinical Safety Evaluation of a Pentavalent DTaP-IPV/Hib Combination Vaccine
979 Reached
Similar Content

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Safe Ramadan Practices during COVID-19 - WHO Guidance
6542 Reached8 Comments3 Likes

How Physicians Should Manage Stress?
35339 Reached151 Comments202 Likes

Managing Meconium Aspiration Syndrome in Infants
9817 Reached7 Comments8 Likes
